What does Ajanta Pharma do?

Jun 06 2025 04:55 PM IST
share
Share Via
Ajanta Pharma Ltd. is a large-cap specialty pharmaceutical formulation company, reporting net sales of ₹1,170 Cr and a net profit of ₹225 Cr for Q1 2025. It has a market cap of ₹32,185 Cr and key metrics include a P/E ratio of 35.00 and a dividend yield of 1.09%.
Overview:
Ajanta Pharma Ltd. is a specialty pharmaceutical formulation company operating in the Pharmaceuticals & Biotechnology industry, categorized as a Large Cap entity.

History:
Ajanta Pharma was incorporated in an unspecified year and has maintained its status as a specialty pharmaceutical company. The latest quarterly results reported are for March 2025, showing net sales and profit figures.

Financial Snapshot:
- Net Sales: 1,170 Cr (Quarterly Results - Mar 2025)
- Net Profit: 225 Cr (Quarterly Results - Mar 2025)
- Market Cap: Rs 32,185 Cr (Large Cap)

Key Metrics:
- P/E: 35.00
- Industry P/E: 35
- Dividend Yield: 1.09%
- Debt-Equity: -0.13
- Return on Equity: 25.39%
- Price to Book: 8.89

Contact Details:
- Address: Ajanta House, Charkop Kandivli (W) Mumbai Maharashtra : 400067
- Phone: 91-22-66061000/1204/1203
- Email: info@ajantapharma.com
- Website: http://www.ajantapharma.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News